Paul Schaffer

Chief Tech/Sci/R&D Officer at ARTMS, Inc.

Health Technology

Profile

Paul Schaffer is currently the Chief Technology Officer at ARTMS, Inc. He previously worked as the Director at Centre For Probe Development & Commercialization from 2018 to 2021.

Paul Schaffer active positions

Companies	Position	Start
ARTMS, Inc. ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada.	Chief Tech/Sci/R&D Officer	28/03/2018

All active positions of Paul Schaffer

Former positions of Paul Schaffer

Companies	Position	End
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Director/Board Member	17/06/2021

See the detail of Paul Schaffer's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Schaffer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
ARTMS, Inc. ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada.	Health Technology
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Health Technology